Amarin Corp Plcuk (AMRN) Operating Expenses (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Operating Expenses of $29.1 million for Q1 2026, down 30.52% YoY from $41.9 million in Q1 2025, and down 1.33% sequentially from $29.5 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Operating Expenses (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Operating Expenses across 17 years of filings, most recently posting $29.1 million for Q1 2026.

  • In Q1 2026, Operating Expenses fell 30.52% year-over-year to $29.1 million; the TTM figure through Mar 2026 stood at $158.3 million (down 6.68% YoY), while the FY2025 annual figure was $171.0 million, down 1.24% from the prior year.
  • Operating Expenses slipped to $29.1 million in Q1 2026, from $29.5 million in the prior quarter.
  • Over the last five years, Operating Expenses for AMRN reached as high as $106.5 million in Q2 2022 and fell as low as $29.1 million in Q1 2026.
  • The 5-year median for Operating Expenses is $50.0 million (2023), against an average of $56.2 million.
  • Annual changes were most pronounced in 2022 — Operating Expenses tumbled 45.55% — and 2025, when it jumped 53.25%.
  • A 5-year view of Operating Expenses shows it stood at $73.2 million in 2022, then plunged by 31.74% to $50.0 million in 2023, then retreated by 14.02% to $43.0 million in 2024, then sank by 31.34% to $29.5 million in 2025, then fell by 1.33% to $29.1 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods registered $29.1 million, $29.5 million, and $33.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 6.72 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 9.59 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 11.01 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -8.41 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 19.82 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 5.95 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 4.37 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 5.50 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 29.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 29.10 Mn
Dec 31, 2025 29.49 Mn
Sep 30, 2025 33.31 Mn
Jun 30, 2025 66.35 Mn
Mar 31, 2025 41.89 Mn
Dec 31, 2024 42.96 Mn
Sep 30, 2024 41.44 Mn
Jun 30, 2024 43.29 Mn
Mar 31, 2024 45.49 Mn
Dec 31, 2023 49.96 Mn
Sep 30, 2023 51.27 Mn
Jun 30, 2023 66.63 Mn
Mar 31, 2023 65.27 Mn
Dec 31, 2022 73.19 Mn
Sep 30, 2022 68.00 Mn
Jun 30, 2022 106.46 Mn
Mar 31, 2022 100.70 Mn
Dec 31, 2021 97.72 Mn
Sep 30, 2021 124.90 Mn
Jun 30, 2021 113.56 Mn